Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients

QR Code

Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients

Introduction. High incidence and mortality rates of colorectal cancer indicate an urgent need for the use of new highly specific diagnostic and prognostic molecular markers. In this aspect, cancer testis antigens (CTA s) are of particular interest.The aim of the study was to analyze the relationship...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. S. Kutilin, O. I. Kit
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2022-03-01
Series:	Сибирский онкологический журнал
Subjects:	colorectal cancer cancer-testis antigens expression metastases survival
Online Access:	https://www.siboncoj.ru/jour/article/view/2026
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECT OF ANTHRACYCLINE ANTITUMOR ANTIBIOTICS UPON TRANSCRIPTION ACTIVITY OF CANCER-TESTIS ANTIGENS IN MODEL EXPERIMENTS WITH HeLa CELLS
by: D. S. Kutilin, et al.
Published: (2019-07-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Impact of tumor diameter on post-radiofrequency ablation survival and local progression risk in patients with colorectal cancer lung metastasis
by: YING Leilei, LI Kening, CHEN Chao, WANG Ying, HUANG Haozhe, WANG Biao, LI Wentao, HE Xinhong
Published: (2025-05-01)

PROGNOSTIC FACTORS IN THE TREATMENT OF LUNG METASTASES FROM COLORECTAL CANCER
by: B. B. Akhmedov, et al.
Published: (2018-05-01)

Incidence, characteristics, and survival in early- and late-onset colorectal cancer
by: Tanja Hukkinen, et al.
Published: (2025-07-01)

Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2023-05-01)

Variability in surgical treatment of metastatic colorectal cancer (literature review)
by: A. Yu. Dobrodeev, et al.
Published: (2023-05-01)

TRANSCRIPTIONAL PROFILE OF CANCER-TESTICULAR ANTIGENS IN PATIENTS WITH BREAST CANCER
by: D. I. Vodolazhskiy, et al.
Published: (2018-06-01)

Stereotactic body radiation therapy for colorectal liver metastases
by: Issa Mohamad, et al.
Published: (2022-12-01)

CHEMOEMBOLIZATION FOR UNRESECTABLE COLORECTAL LIVER METASTASES WITH DRUG-ELUTING MICROSPHERES
by: A. V. Skupchenko, et al.
Published: (2016-02-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Improvement of long-term treatment results in oligometastatic colorectal cancer patients by using a combined approach
by: E. O. Kalmykova, et al.
Published: (2024-12-01)

The association between neutrophil percentage to albumin ratio and progression-free survival and overall survival in colorectal cancer patients: a retrospective cohort study
by: Hailun Xie, et al.
Published: (2025-07-01)

Thermal ablation in the management of oligometastatic colorectal cancer
by: Thierry De Baere, et al.
Published: (2022-12-01)

TO THE PROBLEM OF CHOICE OF THE TREATMENT TACTICS IN METASTATIC COLORECTAL CANCE
by: A. Z. Azanov, et al.
Published: (2016-04-01)

MINIMALLY INVASIVE TECHNOLOGIES IN TREATMENT OF COLORECTAL CANCER WITH LIVER METASTASES
by: V. E. Kolesnikov
Published: (2016-09-01)

Overview of the Surgical Management of Liver Oligometastatic Disease in Colorectal Cancer
by: Anca Monica Oprescu Macovei, et al.
Published: (2025-05-01)

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
by: A. A. Solodovnik, et al.
Published: (2018-07-01)

Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
by: Lina Lin, et al.
Published: (2021-12-01)

Prognostic Factors Influencing the Efficacy of Regorafenib in the Treatment of Metastatic Colorectal Cancer
by: Nadiye SEVER, et al.
Published: (2025-06-01)

Main aspects of personalized approach to the treatment of patients with chemotherapy resistant metastatic colorectal cancer
by: O. Yu. Stukalova, et al.
Published: (2024-12-01)

Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
by: A. Yu. Dobrodeev, et al.
Published: (2023-01-01)

An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer
by: Kenji Murata, et al.
Published: (2025-12-01)

Genes copy number variation in colorectal cancer patients as a marker of the disease clinical outcome and response to therapy
by: A. A. Maslov, et al.
Published: (2022-06-01)

Long-term survival after adrenal metastasectomy from colorectal cancer: a report of two cases
by: Akinori Tsujimoto, et al.
Published: (2019-04-01)

Current trends and outcomes of surgical treatment of colorectal cancer with liver metastasis
by: A. V. Shabunin, et al.
Published: (2022-11-01)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
by: Kozue Matsuishi, et al.
Published: (2020-06-01)

Xenogeneic Testicular Cell Vaccination Induces Long-Term Anti-Cancer Immunity in Mice
by: Victor I. Seledtsov, et al.
Published: (2025-06-01)

Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective Study
by: Sixuan Li, et al.
Published: (2025-06-01)

MICROSATELLITE-UNSTABLE COLORECTAL CANCER IN ELDERLY PATIENTS: CLINICAL FEATURES AND THE ROLE OF IMMUNODEFICIENCY
by: D. V. Pashkov, et al.
Published: (2020-03-01)

СOMPARATIVE ANALYSIS OF 10-YEAR RESULTS OF TREATMENT EFFICACY IN PATIENTS WITH COLORECTAL CARCINOMA
by: R. A. Murashko, et al.
Published: (2018-05-01)

Liver metastases in patients with curatively treated colorectal cancer
by: R. I. Rasulov, et al.
Published: (2019-02-01)

Combining Preoperative and Postoperative Prognostic Nutritional Index as an Improved Prognostic Factor for Overall Survival in Patients with Colorectal Cancer
by: Lee JM, et al.
Published: (2025-07-01)

Oncological aid for colorectal cancer patients in Tomsk area: ways of cancer prevention
by: L. D. Zhuykova, et al.
Published: (2014-12-01)

The Significance of Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, Calcium and Zinc as Biomarkers in Sera of Colorectal Cancer Patients
by: Fenik Ahmed Nadir, et al.
Published: (2024-12-01)

Features of some transcription factors gene expression in the malignancy tissues of the corpus uteri
by: D. S. Kutilin, et al.
Published: (2019-04-01)

Contemporary evidence on colorectal liver metastases ablation: toward a paradigm shift in locoregional treatment
by: Yuan-Mao Lin, et al.
Published: (2022-12-01)

ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
by: I. N. Mikhaylova, et al.
Published: (2021-06-01)

Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer—is it justified?
by: R.D. Peixoto, et al.
Published: (2025-09-01)

Elevated Methylation Contributes to Suppressed Expression of Special AT‐Rich Sequence‐Binding Protein 2 in Colorectal Cancer: A Gene‐Disease Association Study
by: Weitong Cui, et al.
Published: (2025-07-01)